HMDB0004701 | 9,10-Epoxyoctadecenoic acid | | | C18H32O3 | 296.4449 296.23514489 | Not Available |
HMDB0004702 | 12,13-EpOME | | | C18H32O3 | 296.4449 296.23514489 | Not Available |
HMDB0004995 | Codeine | 76-57-3 | | C18H21NO3 | 299.3642 299.152143543 | Not Available |
HMDB0005008 | Lansoprazole | 103577-45-3 | | C16H14F3N3O2S | 369.361 369.075882012 | Not Available |
HMDB0005010 | Sertraline | 79617-96-2 | | C17H17Cl2N | 306.23 305.073804963 | Not Available |
HMDB0005014 | Celecoxib | 169590-42-5 | | C17H14F3N3O2S | 381.372 381.075882012 | Not Available |
HMDB0005017 | Pantoprazole | 102625-70-7 | | C16H15F2N3O4S | 383.37 383.075133083 | Not Available |
HMDB0005022 | Pravastatin | 81093-37-0 | | C23H36O7 | 424.5277 424.246103506 | Not Available |
HMDB0005031 | Rosiglitazone | 122320-73-4 | | C18H19N3O3S | 357.427 357.114712179 | Not Available |
HMDB0005033 | Valdecoxib | 181695-72-7 | | C16H14N2O3S | 314.359 314.072513014 | Not Available |
HMDB0005038 | Citalopram | 59729-33-8 | | C20H21FN2O | 324.3919 324.163791509 | Not Available |
HMDB0005039 | Sildenafil | 139755-83-2 | | C22H30N6O4S | 474.576 474.204924168 | Not Available |
HMDB0005050 | 15H-11,12-EETA | 877878-78-9 | | C20H32O4 | 336.4657 336.230059512 | Not Available |
HMDB0006768 | 19-Oxoandrost-4-ene-3,17-dione | | | C19H24O3 | 300.3921 300.172544634 | Not Available |
HMDB0006769 | 19-Hydroxytestosterone | 2126-37-6 | | C19H28O3 | 304.4238 304.203844762 | Not Available |
HMDB0011136 | 19(S)-HETE | 79551-85-2 | | C20H32O3 | 320.4663 320.23514489 | Not Available |
HMDB0012242 | Ketoconazole | 65277-42-1 | | C26H28Cl2N4O4 | 531.431 530.148760818 | Not Available |
HMDB0012567 | 13-HETE | 151910-72-4 | | C20H32O3 | 320.4663 320.23514489 | Not Available |
HMDB0012598 | 17-HETE | | | C20H32O3 | 320.4663 320.23514489 | Not Available |
HMDB0013839 | N-Desmethylaminopyrine | | | C12H15N3O | 217.267 217.121512117 | - Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
- Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
|
HMDB0013840 | 3-Hydroxymethylantipyrine | 18125-49-0 | | C11H12N2O2 | 204.2252 204.089877638 | - Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
- Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
|
HMDB0013842 | O-Deethylated candesartan | | | C22H16N6O3 | 412.4008 412.128388408 | - Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
- Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
- McClellan KJ, Goa KL: Candesartan cilexetil. A review of its use in essential hypertension. Drugs. 1998 Nov;56(5):847-69. [PubMed:9829158 ]
|
HMDB0013845 | SR 49498 | | | C25H30N6O2 | 446.5447 446.243024234 | - Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
- Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
|
HMDB0013846 | E-3179 | | | C22H21ClN6O | 420.895 420.146537031 | - Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
- Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
- Yasar U, Forslund-Bergengren C, Tybring G, Dorado P, Llerena A, Sjoqvist F, Eliasson E, Dahl ML: Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype. Clin Pharmacol Ther. 2002 Jan;71(1):89-98. [PubMed:11823761 ]
- Song JC, White CM: Pharmacologic, pharmacokinetic, and therapeutic differences among angiotensin II receptor antagonists. Pharmacotherapy. 2000 Feb;20(2):130-9. [PubMed:10678291 ]
- Sica DA, Gehr TW, Ghosh S: Clinical pharmacokinetics of losartan. Clin Pharmacokinet. 2005;44(8):797-814. [PubMed:16029066 ]
|
HMDB0013848 | 4-Hydroxyvalsartan | | | C24H29N5O4 | 451.5182 451.221954441 | - Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
- Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
- Nakashima A, Kawashita H, Masuda N, Saxer C, Niina M, Nagae Y, Iwasaki K: Identification of cytochrome P450 forms involved in the 4-hydroxylation of valsartan, a potent and specific angiotensin II receptor antagonist, in human liver microsomes. Xenobiotica. 2005 Jun;35(6):589-602. [PubMed:16192110 ]
|